Stoke Therapeutics to Present at Upcoming Investor Conferences in March
BEDFORD, Mass., February 26, 2025--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, today announced that management will present at the following upcoming investor conferences:
TD Cowen 45th Annual Healthcare ConferenceDate: Wednesday, March 5, 2025Time: 9:50 a.m. ET
Leerink Partners Global Healthcare ConferenceDate: Monday, March 10, 2025Time: 10:40 a.m. ET
Live webcasts of each event, along with archived replays, will be available in the Investors & News section of Stoke's website at https://investor.stoketherapeutics.com/.
About Stoke TherapeuticsStoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is expected to enter Phase 3 development in 2025. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for the Company's proprietary approach. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts. For more information, visit https://www.stoketherapeutics.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250226132780/en/
Contacts
Stoke Media & Investor Contacts: Dawn KalmarChief Communications Officerdkalmar@stoketherapeutics.com 781-303-8302
Doug SnowDirector, Communications & Investor RelationsIR@stoketherapeutics.com 508-642-6485
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Warren officials considering forming Joint Economic District with nearby township
WARREN, Ohio (WKBN) — The City of Warren is exploring a new way to boost economic development by partnering with a nearby township to create a Joint Economic District. The move could pave the way for major improvements in the area, all with an eye toward a major player — Kimberly-Clark, which announced it will build a manufacturing plant in Warren last month. Ohio Laws allow municipalities and townships to join forces and identify prime property for development and even tax themselves to fund improvements. In Warren's case, the city would serve as the municipal partner, supplying water and sewer services, while the district itself would do things like road work, powerline relocations and building new access roads for truck traffic. 'The JED is obviously a creature of statute, and it allows for municipalities and neighboring townships or township to work together where one has something and the other lacks it, and you kind of come together for this purpose,' said Warren Law Director Enzo Cantalamessa. City officials say Kimberly-Clark expects the project to take two to two-and-a-half years to complete, making the partnership a key step in delivering the infrastructure and services necessary for the company's expansion. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
25 minutes ago
- Yahoo
Insurance tech firm Slide targets over $2 billion valuation in Nasdaq IPO
-- Insurance technology company Slide is pursuing a valuation of up to $2.12 billion in its upcoming initial public offering (IPO) on the Nasdaq exchange. The company disclosed the target in a filing on Monday. In collaboration with some of its existing stakeholders, Slide is aiming to raise up to $340 million from the IPO. This move is in line with a recent trend of successful stock market debuts by insurance firms. Barclays and Morgan Stanley have been named as the lead underwriters for the listing. The shares of the company are anticipated to begin trading on the Nasdaq exchange under the ticker symbol "SLDE". Related articles Insurance tech firm Slide targets over $2 billion valuation in Nasdaq IPO Morgan Stanley downgrades Lululemon on weak US growth outlook Tesla shares slip after double downgrade amid Trump feud fallout Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25 minutes ago
- Yahoo
Sitio Royalties downgraded after Viper Energy agrees to acquire co for $19.41/shr
-- Texas Capital has downgraded Sitio Royalties Corp (NYSE:STR) to Hold from Buy after the company agreed to be acquired by Viper Energy (NASDAQ:VNOM) in an all-stock transaction valued at $19.41 per share. The downgrade comes as analysts no longer see material upside following the announced deal, which values Sitio at about $4.1 billion. Texas Capital also cut its price target on Sitio to $20 from $29, in line with the proposed merger terms. 'We are positive on the transaction,' analysts wrote, citing strategic fit, increased scale, low leverage, and an attractive base dividend breakeven below $20 per barrel WTI. 'The combination creates a must-own Minerals company.' Texas Capital does not expect any competing bids given the lack of well-capitalized public rivals in the space. Viper Energy said the deal will make it the largest public mineral and royalty company in the U.S., with positions in the Permian and other key basins. The transaction is expected to close in the second half of 2025, subject to shareholder and regulatory approvals. Related articles Sitio Royalties downgraded after Viper Energy agrees to acquire co for $19.41/shr Tesla shares gain as Trump wishes Musk 'well' GFL weighs sale in infrastructure arm valued at C$5 billion - Bloomberg Sign in to access your portfolio
